Provided by Tiger Trade Technology Pte. Ltd.

Recursion Pharmaceuticals, Inc.

3.50
+0.16004.79%
Post-market: 3.500.00000.00%19:59 EDT
Volume:22.90M
Turnover:80.71M
Market Cap:1.87B
PE:-3.42
High:3.63
Open:3.39
Low:3.37
Close:3.34
52wk High:7.18
52wk Low:2.77
Shares:535.00M
Float Shares:522.33M
Volume Ratio:1.28
T/O Rate:4.38%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.0219
EPS(LYR):-1.4410
ROE:-56.58%
ROA:-27.33%
PB:2.05
PE(LYR):-2.43

Loading ...

Jun 03, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 02, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 22, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 12, 2026

Beneficial Ownership Change

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
May 07, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 06, 2026

Major Issues Report

Form 8-K - Current report
May 06, 2026

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 05, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Apr 30, 2026

Major Issues Report

Form 8-K - Current report
Apr 24, 2026

Beneficial Ownership Change

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Apr 22, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Apr 07, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Apr 07, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 25, 2026

Major Issues Report

Form 8-K - Current report
Mar 23, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 17, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 09, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 03, 2026

Proposed Sale Of Securities

Form 144 | RECURSION PHARMACEUTICALS Director Borgeson Blake proposes to sell 170,000 shares, with a total value of approximately $588,200.
Feb 25, 2026

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Feb 25, 2026

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]